FDA found big problems a year ago at Chinese plant now recalling tainted valsartan
admin 10th August 2018 Uncategorised 0An FDA inspection of the Zhejiang Huahai Pharmaceutical plant a year ahead of its global recall of tainted heart drug valsartan found a plant with little regard for quality control and which blamed out-of-specification test results on “ghost peaks,” lab errors and environmental pollution.
More: FDA found big problems a year ago at Chinese plant now recalling tainted valsartan
Source: fierce